What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors

What Clinicians Want to Know About Toxicity C...

Up next

Oncology Today with Dr Neil Love: Key Presentations on Chronic Lymphocytic Leukemia from the 2023 ASH Annual Meeting

Dr Bita Fakhri from Stanford University in Stanford, California, discusses recent updates from ASH 2023 for the management of chronic lymphocytic leukemia and Richter’s syndrome. 

Relapsed/Refractory Multiple Myeloma — ASH 2025 Review

Dr Sagar Lonial from Winship Cancer Institute of Emory University in Atlanta, Georgia, and Dr María-Victoria Mateos from the University Hospital of Salamanca in Salamanca, Spain, discuss cases of relapsed/refractory multiple myeloma and recentresearch findings from the 2025 ASH A ...  Show more